Gilead Sciences Nears Deal to Buy Immunomedics for More Than $20 Billion, Says Report

Discussions between Gilead and Immunomedics were initially centered around a partnership before shifting to a full-fledged takeover negotiation, the Journal added.

from Top World News- News18.com https://ift.tt/2GX18nl
via IFTTT